Product introduction of Hengrui Pharma Group Co., Ltd.

At present, the company's main products are: anti-tumor drugs, cardiovascular drugs, narcotic analgesics, endocrine drugs. The company's annual production capacity will reach 654.38+0.5 billion tablets, 654.38+0 billion injections, 654.38+0 million soft bag infusion bags, 654.38+0 million bottles of oral liquid, 654.38+0 million capsules and 654.38+0 million ointments. All dosage forms of the company have passed the national GMP certification, and ifosfamide, etoposide, mesna and Tetep have passed the US FDA certification. At the same time, the company is carrying out FDA certification of the preparation, and plans to sell the preparation to European and American markets in 2009.